Clinical Trial Update: Evaluation of the Optimal Dose of GnRH Agonist for Triggering Final Oocyte Maturation in High Risk OHSS Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the optimal GnRH agonist dose to trigger final oocyte maturation in women at high risk for ovarian hyperstimulation s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• GnRH agonist (gonadotropin-releasing hormone agonist)

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Subfertility | Phase 2 | Status: UNKNOWN